Metronidazole/OVA is an antigen-adjuvant conjugate of Metronidazole with ovalbumin (OVA). Conjugating the antigen with a protein adjuvant can enhance the production of antigen-specific antibodies in vaccine models. The conjugate does not interfere with protein folding or disrupt primary epitopes and can improve cross-presentation and the generation of antigen-specific T cells.